24-h blood glucose pattern in type I and type II diabetics after oral treatment with pentoxifylline as assessed by artificial endocrine pancreas - PubMed (original) (raw)
. 1987 Jul-Sep;24(3):181-92.
doi: 10.1007/BF02732036.
Affiliations
- PMID: 3687311
- DOI: 10.1007/BF02732036
24-h blood glucose pattern in type I and type II diabetics after oral treatment with pentoxifylline as assessed by artificial endocrine pancreas
S Raptis et al. Acta Diabetol Lat. 1987 Jul-Sep.
Abstract
Based on the known action of xanthine derivatives on the insulin secretion, the effect of pentoxifylline on carbohydrate homeostasis of type I (IDDM) and type II (NIDDM) diabetics was investigated. Pentoxifylline is known to exert a favorable influence on hemorheological disturbances in such patients. Twenty-four hour blood glucose pattern and insulin requirements were evaluated in type I and type II diabetics by the use of the artificial pancreas before and after a 14-day treatment with pentoxifylline 400 mg p.o. (Trental 400) t.i.d. During the stabilization period before treatment with pentoxifylline, NIDDM patients required 10.1 +/- 3.8 U of insulin and the IDDM 35 +/- 13.7 U. After 2 weeks on pentoxifylline, NIDDM required only 6.3 +/- 2.8 U (p less than 0.05) and IDDM 28.5 +/- 9.7 U (n.s.). Average blood glucose during the 24h decreased by 15.8 +/- 3.5% in NIDDM and by 10.3 +/- 2.5% in IDDM. Moreover, a significant smoothing of glucose fluctuations during the 24h was noted in both groups. It is concluded that pentoxifylline administered concurrently to any antidiabetic type of treatment leads to better blood glucose control as well as to prevention or delay of vascular complications.
Similar articles
- [Behavior of the fasting blood sugar values in diabetics treated with oral and parenteral pentoxifylline].
Tat H, Marx-Heep I, Adams HJ. Tat H, et al. Fortschr Med. 1978 Oct 26;96(40):2053-6. Fortschr Med. 1978. PMID: 711100 German. - Effect of pentoxifylline on carbohydrate metabolism in type II diabetics.
Ambrus JL, Stadler S, Bannerman R. Ambrus JL, et al. Arch Intern Med. 1990 Apr;150(4):921. Arch Intern Med. 1990. PMID: 2327862 No abstract available. - Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
Ferrari E, Fioravanti M, Patti AL, Viola C, Solerte SB. Ferrari E, et al. Pharmatherapeutica. 1987;5(1):26-39. Pharmatherapeutica. 1987. PMID: 3602021 - Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
Chopra HK, Chopra KL, Aggarwal KK, Parashar SK. Chopra HK, et al. J Med. 1988;19(2):89-107. J Med. 1988. PMID: 3049876 Review. - Continuous Glucose Monitoring in 2017.
Battelino T, Bode BW. Battelino T, et al. Diabetes Technol Ther. 2018 Feb;20(S1):S13-S29. doi: 10.1089/dia.2018.2502. Diabetes Technol Ther. 2018. PMID: 29437476 Review. No abstract available.
Cited by
- Are the Protean Effects of Pentoxifylline in the Therapy of Diabetes and Its Complications Still Relevant?
Bell DSH. Bell DSH. Diabetes Ther. 2021 Dec;12(12):3025-3035. doi: 10.1007/s13300-021-01168-x. Epub 2021 Oct 13. Diabetes Ther. 2021. PMID: 34647189 Free PMC article. Review. - Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system.
Azhar A, El-Bassossy HM. Azhar A, et al. J Endocrinol Invest. 2015 Apr;38(4):437-45. doi: 10.1007/s40618-014-0209-z. Epub 2014 Nov 21. J Endocrinol Invest. 2015. PMID: 25412944 - Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Hotamisligil GS, et al. J Clin Invest. 1995 May;95(5):2409-15. doi: 10.1172/JCI117936. J Clin Invest. 1995. PMID: 7738205 Free PMC article. - Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study.
Han SJ, Kim HJ, Kim DJ, Sheen SS, Chung CH, Ahn CW, Kim SH, Cho YW, Park SW, Kim SK, Kim CS, Kim KW, Lee KW. Han SJ, et al. Diabetol Metab Syndr. 2015 Jul 19;7:64. doi: 10.1186/s13098-015-0060-1. eCollection 2015. Diabetol Metab Syndr. 2015. PMID: 26300986 Free PMC article.
References
- Med Monatsschr. 1973 Aug;27(8):353-6 - PubMed
- Nature. 1967 Feb 18;213(5077):727-8 - PubMed
- Eur Neurol. 1983;22 Suppl 1:105-7 - PubMed
- Acta Diabetol Lat. 1977 Sep-Dec;14(5-6):263-72 - PubMed
- Arzneimittelforschung. 1971 Aug;21(8):1160-71 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical